Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Hematopathology
Published in: Journal of Hematopathology 1/2016

01-03-2016 | Editorial

We need to be (much) better

Author: J. H. van Krieken

Published in: Journal of Hematopathology | Issue 1/2016

Login to get access

Excerpt

It is now well recognised that optimal care for lymphoma patients starts with an optimal diagnosis. Tools to get to a correct diagnosis are the regularly updated WHO classification, teaching and workshops from (among others) the European Association of Haematopathology and the Society of Hematopathology and the increasing amount of books and articles on the pathology of lymphoma. This enormous amount of knowledge is being used by haematopathologists all over the world and they increasingly rely on techniques like immunohistochemistry and molecular biology. …
Metadata
Title
We need to be (much) better
Author
J. H. van Krieken
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Hematopathology / Issue 1/2016
Print ISSN: 1868-9256
Electronic ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-016-0268-5

Other articles of this Issue 1/2016

Journal of Hematopathology 1/2016 Go to the issue

Case Report

Primary dural lymphoblastic B-cell lymphoma: a rare subtype of aggressive dural lymphoma

Original Article

A subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma

Case Report

Myeloid blast phase of chronic myelogenous leukemia, BCR-ABL1+, associated with a secondary translocation involving MLL: case report and review of the literature

Letter to the editor

Aggressive T-LGL or indolent Hepatosplenic T-cell lymphoma: case with a difficult differential diagnosis

Original Article

Clinical utility of morphology, immunohistochemistry, flow cytometry, and FISH analysis in monitoring of plasma cell neoplasms in the bone marrow

Review of the Literature

New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015